Abeprazan hydrochloride
Abeprazan hydrochloride (Fexuprazan hydrochloride) is an orally active, reversible potassium-competitive acid blocker (P-CAB) that inhibits gastric H+/K+-ATPase. It is used in research for investigating gastric acid-related disorders like GERD and peptic ulcers, with applications in both in vitro mechanistic studies and in vivo pharmacological models.
Product Specifications
CAS Number
1902954-87-3
Product Name Alternative
Abeprazan Hydrochloride, DWP 14012 Hydrochloride, DWP14012 Hydrochloride, DWP14012 hydrochloride, DWP-14012 Hydrochloride, Fexuprazan Hydrochloride, Fexuprazan hydrochloride, Protonpump, Proton pump
Field of Research
Pharmacology & Drug Discovery
Purity
98.57% (May vary between batches)
Solubility
DMSO:40 mg/mL (89.51 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.48 mM)
Smiles
Cl.CNCc1cn (c (c1OC) -c1ccc (F) cc1F) S (=O) (=O) c1cccc (F) c1
Molecular Formula
C19H18ClF3N2O3S
Molecular Weight
446.87
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
